Compare Becton Dickinson and Co (BDX) vs Check Point Software Technologies Ltd (CHKP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Check Point Software Technologies Ltd — how do they compare? Becton Dickinson and Co trades at $185 (market cap $50.32B), while Check Point Software Technologies Ltd trades at $133.01 (market cap $13.99B). The key difference: Becton Dickinson and Co is far larger — about 3.6× Check Point Software Technologies Ltd's market cap, and Becton Dickinson and Co pays a 2.27% dividend while Check Point Software Technologies Ltd pays none. Which is the better fit depends on your goals.
| BDX | CHKP | |
|---|---|---|
Market Cap | $50.32B | $13.99B |
Sector | Health | Technology |
52-Week High | $192.00 | $206.91 |
52-Week Low | $138.62 | $112.47 |
Enterprise Value | $66.42B | $13.69B |
Dividend Yield | 2.27% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $179.97, down 2.58% today, with a bullish technical signal from moving averages and oversold RSI-6 at 19.23. The company reported Q2 2026 EPS of $3.23, beating estimates, and maintains a 47% gross margin. Recent news highlights clinical trial progress in tissue regeneration and a new quality officer appointment. Analyst consensus is a $186.38 price target with 16 buy, 17 hold, and 1 sell ratings.
Outlook remains stable with revenue growth and dividend consistency, but risks include margin pressure and high debt. The stock offers value near support levels, with institutional sentiment balanced between growth potential and execution risks in the healthcare sector.
Check Point Software (CHKP) trades at $133.25, down 2.77% on the day, amid a broader market decline. The stock exhibits a bullish technical trend with strong moving average signals, though oscillators are neutral. Fundamentally, the company maintains robust profitability with a 37.93% net income margin and has beaten earnings estimates for the last three quarters. Recent news highlights its AI-driven cybersecurity products and a consensus analyst price target of $146.92, suggesting potential upside.
The outlook for CHKP is cautiously optimistic, supported by solid fundamentals and AI growth initiatives, but faces risks from competitive pressures and potential margin compression. Investor sentiment is mixed, with analysts predominantly holding a neutral to buy stance. The key opportunity lies in the execution of its AI security platform, while macroeconomic headwinds and insider selling pose near-term challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Check Point Software Technologies Ltd
Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.
Read more on CHKP →
